Leyla Ramazanoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leyla Ramazanoglu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Işıl Kalyoncu Aslan
Fatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi
5 shared publications Murat Velioglu
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital, Department of Radiology, Istanbul, Turkey
4 shared publicationsEren Gozke
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital, Department of Neurology, Istanbul, Turkey
3 shared publications- Eren Gözke
Department of Neurology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
3 shared publications Isil Kalyoncu Aslan
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital, Department of Neurology, Istanbul, Turkey
3 shared publicationsYilmaz Onal
University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital
3 shared publications
Latest Publications
- 30 June 2026
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Predictive ability of cardiac biomarkers for early risk stratification and 3-month functional outcomes after reperfusion therapy in acute ischemic stroke
This study aimed to determine the prognostic value of baseline serum cardiac biomarkers measured at emergency department admission in patients with acute ischemic stroke undergoing reperfusion therapy. This retrospective cohort study evaluated data from 433 AIS patients treated with intravenous thrombolysis (IVT), mechanical thrombectomy (MT), or combined therapy. Serum lactate dehydrogenase, creatine kinase, plasma N-terminal pro-brain natriuretic peptide, and high-sensitivity cardiac troponin T levels were analyzed. Stroke severity, functional outcomes, hemorrhagic transformation, and mortality were assessed. Continuous variables were evaluated using the Shapiro-Wilk test, Kruskal-Wallis ANOVA, and post-hoc pairwise comparisons. Diagnostic efficacy was calculated using ROC-AUC and the Youden Index. Independent risk factors were identified via Multivariate Logistic Regression analysis. High-sensitivity cTnT predicted functional prognosis at both discharge and 3 months, whereas LDH predicted outcomes exclusively at 3 months. Elevated CK and LDH levels correlated significantly with stroke etiology. An hs-cTnT value > 10.5 pg/mL independently increased the risk of poor discharge prognosis (OR: 1.725, p < 0.05). In multivariate logistic regression, age, baseline NIHSS, and hs-cTnT were independent risk factors for poor discharge outcomes. For 3-month mRS scores, the optimal prognostic cut-off values were > 200 U/L for LDH (p = 0.003) and >10.5 pg/mL for hs-cTnT (p = 0.007). In the final multivariate model, baseline NIHSS, stroke etiology, LDH (>200 U/L, OR: 1.845, p < 0.05), and hs-cTnT (>10.5 pg/mL, OR: 1.685, p < 0.05) emerged as independent risk factors for a poor 3-month prognosis. Integrating admission cardiac biomarkers into clinical evaluation scores significantly enhances risk stratification and predictive accuracy in acute ischemic stroke management.
- 30 June 2026
- Published by Taylor & Francis in Neurological Research
- p. 1-9
Predictive ability of cardiac biomarkers for early risk stratification and 3-month functional outcomes after reperfusion therapy in acute ischemic stroke
This study aimed to determine the prognostic value of baseline serum cardiac biomarkers measured at emergency department admission in patients with acute ischemic stroke undergoing reperfusion therapy. This retrospective cohort study evaluated data from 433 AIS patients treated with intravenous thrombolysis (IVT), mechanical thrombectomy (MT), or combined therapy. Serum lactate dehydrogenase, creatine kinase, plasma N-terminal pro-brain natriuretic peptide, and high-sensitivity cardiac troponin T levels were analyzed. Stroke severity, functional outcomes, hemorrhagic transformation, and mortality were assessed. Continuous variables were evaluated using the Shapiro-Wilk test, Kruskal-Wallis ANOVA, and post-hoc pairwise comparisons. Diagnostic efficacy was calculated using ROC-AUC and the Youden Index. Independent risk factors were identified via Multivariate Logistic Regression analysis. High-sensitivity cTnT predicted functional prognosis at both discharge and 3 months, whereas LDH predicted outcomes exclusively at 3 months. Elevated CK and LDH levels correlated significantly with stroke etiology. An hs-cTnT value > 10.5 pg/mL independently increased the risk of poor discharge prognosis (OR: 1.725, p < 0.05). In multivariate logistic regression, age, baseline NIHSS, and hs-cTnT were independent risk factors for poor discharge outcomes. For 3-month mRS scores, the optimal prognostic cut-off values were > 200 U/L for LDH (p = 0.003) and >10.5 pg/mL for hs-cTnT (p = 0.007). In the final multivariate model, baseline NIHSS, stroke etiology, LDH (>200 U/L, OR: 1.845, p < 0.05), and hs-cTnT (>10.5 pg/mL, OR: 1.685, p < 0.05) emerged as independent risk factors for a poor 3-month prognosis. Integrating admission cardiac biomarkers into clinical evaluation scores significantly enhances risk stratification and predictive accuracy in acute ischemic stroke management.
- Open Access
- 29 December 2025
- Published by Brawijaya University in MNJ (Malang Neurology Journal)
- Vol. 12 (1) , 57-62
IMPACT OF TRIGLYCERIDE GLUCOSE INDEX AND TG/HDL RATIO ON TREATMENT OUTCOMES IN ACUTE ISCHEMIC STROKE
Background: Insulin resistance is one of the modifiable risk factors for ischemic stroke. Objective: This study aimed to investigate the relationship between treatment success, complications, and the functional status of the patients at 3 months follow up, Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values in patients who were received intravenous thrombolytic and/or mechanical thrombectomy treatments. Methods: A total of 432 patients aged over 18 years who were treated for acute ischemic stroke were included in the study. The Triglyceride Glucose index was computed using the formula Ln (Fasting Blood Sugar (mg/dl) x Fasting Triglyceride Level (mg/dl)/2) based on blood samples taken on the first day of hospitalization. Etiological evaluation of stroke was performed according to the TOAST classification. Results: Twenty-four hours following intravenous thrombolysis and/or mechanical thrombectomy, patients exhibiting elevated Triglyceride/Glucose index values demonstrated higher NIHSS scores. Moreover, individuals diagnosed with large vessel occlusions had significantly increased Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein ratio levels compared to those with cardioembolic stroke etiology. On the other hand, no meaningful association was identified between Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values and the duration of hospitalization or modified rankin score outcomes. Conclusion: In this study, no strong evidence was shown regarding the relationship between Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values and treatment-related complications and functional status at 3-month follow-up in patients who underwent iv thrombolytic and mechanical thrombectomy treatment due to acute ischemic stroke. Prospective studies with longer follow-up of patients are needed on this subject.
- 29 December 2025
- Published by Brawijaya University in MNJ (Malang Neurology Journal)
- Vol. 12 (1) , 57-62
Open AccessIMPACT OF TRIGLYCERIDE GLUCOSE INDEX AND TG/HDL RATIO ON TREATMENT OUTCOMES IN ACUTE ISCHEMIC STROKE
Background: Insulin resistance is one of the modifiable risk factors for ischemic stroke. Objective: This study aimed to investigate the relationship between treatment success, complications, and the functional status of the patients at 3 months follow up, Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values in patients who were received intravenous thrombolytic and/or mechanical thrombectomy treatments. Methods: A total of 432 patients aged over 18 years who were treated for acute ischemic stroke were included in the study. The Triglyceride Glucose index was computed using the formula Ln (Fasting Blood Sugar (mg/dl) x Fasting Triglyceride Level (mg/dl)/2) based on blood samples taken on the first day of hospitalization. Etiological evaluation of stroke was performed according to the TOAST classification. Results: Twenty-four hours following intravenous thrombolysis and/or mechanical thrombectomy, patients exhibiting elevated Triglyceride/Glucose index values demonstrated higher NIHSS scores. Moreover, individuals diagnosed with large vessel occlusions had significantly increased Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein ratio levels compared to those with cardioembolic stroke etiology. On the other hand, no meaningful association was identified between Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values and the duration of hospitalization or modified rankin score outcomes. Conclusion: In this study, no strong evidence was shown regarding the relationship between Triglyceride/Glucose index and Triglyceride/High Density Lipoprotein values and treatment-related complications and functional status at 3-month follow-up in patients who underwent iv thrombolytic and mechanical thrombectomy treatment due to acute ischemic stroke. Prospective studies with longer follow-up of patients are needed on this subject.
- 31 August 2025
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 9 (2) , 265-273
Bilateral Internal Carotid Artery Stenosis: Risk Factors and Prognosis
Aim: Internal carotid artery stenosis may lead to ischemic events, temporary/permanent vision loss, and cognitive impairment. The aim of this study was to evaluate the association between risk factors for bilateral internal carotid artery stenosis (BICAS) and stroke, fundus findings, and cognitive impairment. Material and Methods: Patients who applied to the neurology outpatient clinic for any reason and were diagnosed with BIKAD by carotid doppler duplex ultrasonography and/or Computed Tomography Angiography were included in this study. Three groups were created for BICAS: (A) Severe stenosis in both arteries, (B) Severe stenosis in one artery and moderate stenosis in the other, and (C) Moderate stenosis in both arteries. Patients with a history of cerebral ischemic stroke or imaging findings were grouped as symptomatic, while others were asymptomatic. Those who were able to comply underwent fundus evaluation with an ophthalmoscope and mini-mental state examination (MMSE) by an experienced neurologist. The symptomatic group was also classified as those who received endovascular treatment and those who followed with the best medical treatment. Results: Eighty-six patients were evaluated. BICAS was higher in patients over 70 years and in males. In addition, patients in groups A and B had a higher risk of stroke. Cognitive impairment, ocular findings, and stenting rate were higher in group A. Conclusion: Cognitive impairment, ocular findings and stroke rates are higher in BICAS patients. Funduscopic examination and MMSE findings should be taken into consideration as non-invasive methods in the diagnosis of asymptomatic patients, and patients should be referred for further examination and treatment.
- 31 August 2025
- Published by Bulent Evcevit University in Medical Journal of Western Black Sea
- Vol. 9 (2) , 265-273
Bilateral Internal Carotid Artery Stenosis: Risk Factors and Prognosis
Aim: Internal carotid artery stenosis may lead to ischemic events, temporary/permanent vision loss, and cognitive impairment. The aim of this study was to evaluate the association between risk factors for bilateral internal carotid artery stenosis (BICAS) and stroke, fundus findings, and cognitive impairment. Material and Methods: Patients who applied to the neurology outpatient clinic for any reason and were diagnosed with BIKAD by carotid doppler duplex ultrasonography and/or Computed Tomography Angiography were included in this study. Three groups were created for BICAS: (A) Severe stenosis in both arteries, (B) Severe stenosis in one artery and moderate stenosis in the other, and (C) Moderate stenosis in both arteries. Patients with a history of cerebral ischemic stroke or imaging findings were grouped as symptomatic, while others were asymptomatic. Those who were able to comply underwent fundus evaluation with an ophthalmoscope and mini-mental state examination (MMSE) by an experienced neurologist. The symptomatic group was also classified as those who received endovascular treatment and those who followed with the best medical treatment. Results: Eighty-six patients were evaluated. BICAS was higher in patients over 70 years and in males. In addition, patients in groups A and B had a higher risk of stroke. Cognitive impairment, ocular findings, and stenting rate were higher in group A. Conclusion: Cognitive impairment, ocular findings and stroke rates are higher in BICAS patients. Funduscopic examination and MMSE findings should be taken into consideration as non-invasive methods in the diagnosis of asymptomatic patients, and patients should be referred for further examination and treatment.
- 19 April 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 254, 108892
Endovascular versus medical management of posterior cerebral artery occlusion stroke
- 19 April 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 254, 108892
Endovascular versus medical management of posterior cerebral artery occlusion stroke
- 5 February 2025
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (6) , 712-719
Predictors of prognosis in stroke patients with tandem lesions who undergo emergent stenting
Background: The optimal endovascular approach for tandem lesions (extracranial internal carotid artery and intracranial large vessel occlusion) is not clear. Aims: The aim was to evaluate the follow-up results of stroke patients with tandem lesions who underwent emergent stenting of extracranial lesions with antithrombotic therapy combined with intracranial MT Methods: Outcomes and predictors of poor prognosis and mortality compared with those of good prognosis at 90 days, 1 year, and 2 years were assessed. A modified Rankin scale (mRS) score was used. Symptomatic intracranial hemorrhage (sICH), National Institutes of Health Stroke Scale (NIHSS) scores at admission and at 24 h, successful recanalization, asymptomatic ICH, embolization, malignant infarction, decompression, in-stent restenosis and extracranial complications were also evaluated. The best age cutoff for predicting mortality was analyzed Results: A total of 71 subjects were included. Using patients with a good prognosis as a reference, the independent variables predicting a poor prognosis were a high 24-h NIHSS score and extracranial complications at all timepoints (3-month, 1-year, and 2-year follow-up). The most appropriate age cutoff for predicting 1-year mortality was 67 years [AUC = 0.802 (95% CI = 0.684–0.920); p < .001]. The age cutoff determined for the first year was correlated with the prediction of mortality in the third month and the second year. No significant association was observed between sICH and the groups Conclusion: In this study, the 24-h NIHSS score after reperfusion and age were predictors of poor prognosis and mortality in stroke patients with tandem lesions who underwent emergent stenting during thrombectomy.
- 5 February 2025
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 38 (6) , 712-719
Predictors of prognosis in stroke patients with tandem lesions who undergo emergent stenting
Background: The optimal endovascular approach for tandem lesions (extracranial internal carotid artery and intracranial large vessel occlusion) is not clear. Aims: The aim was to evaluate the follow-up results of stroke patients with tandem lesions who underwent emergent stenting of extracranial lesions with antithrombotic therapy combined with intracranial MT Methods: Outcomes and predictors of poor prognosis and mortality compared with those of good prognosis at 90 days, 1 year, and 2 years were assessed. A modified Rankin scale (mRS) score was used. Symptomatic intracranial hemorrhage (sICH), National Institutes of Health Stroke Scale (NIHSS) scores at admission and at 24 h, successful recanalization, asymptomatic ICH, embolization, malignant infarction, decompression, in-stent restenosis and extracranial complications were also evaluated. The best age cutoff for predicting mortality was analyzed Results: A total of 71 subjects were included. Using patients with a good prognosis as a reference, the independent variables predicting a poor prognosis were a high 24-h NIHSS score and extracranial complications at all timepoints (3-month, 1-year, and 2-year follow-up). The most appropriate age cutoff for predicting 1-year mortality was 67 years [AUC = 0.802 (95% CI = 0.684–0.920); p < .001]. The age cutoff determined for the first year was correlated with the prediction of mortality in the third month and the second year. No significant association was observed between sICH and the groups Conclusion: In this study, the 24-h NIHSS score after reperfusion and age were predictors of poor prognosis and mortality in stroke patients with tandem lesions who underwent emergent stenting during thrombectomy.
- Open Access
- 29 April 2024
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 25 (2) , 135-142
İNMENİN YAŞ GRUPLARINA GÖRE DAĞILIMI - İSTANBUL'DA BİR İNME MERKEZİNİN DENEYİMLERİ
AMAÇ: İnme her yaşta görülebilen bir hastalıktır. İleri yaş hem hemorajik inme hem de iskemik inme için değiştirilemez risk faktörüdür ve ilerleyen on yıllarla birlikte risk artışı belirginleşir. Bu çalışmada akut inme hastalarının yaş gruplarına göre cinsiyet, inme etiyolojisi, uygulanan akut iskemi tedavileri, iskemi lokalizasyonu ve nedenleri arasındaki farklılıkların ortaya konulması amaçlandı. GEREÇ VE YÖNTEM: Eylül 2017 - Eylül 2020 arasında serebrovasküler olay tanısı ile yatarak tedavi gören ardışık 3665 hastanın yaş, cinsiyet, inme tipi, akut iskemik inme tedavisi ve etiyolojik sınıflamasına ait bilgileri retrospektif olarak değerlendirildi. BULGULAR: Hastaların 302’si hematom (%8,24), 51’i (%1,39) subaraknoid kanama (SAK), 13’ü (%0,35) serebral venöz tromboz (SVT), 3299’u (%90) geçici iskemik atak (GİA)/iskemik inme tanısı aldı. Kadınlarda inme sıklığı 65 yaş üzerinde artmaktaydı. İntraserebral hematom en sık 65-84 yaş aralığındaydı, %55,3’ü erkekti. SAK en sık 45-54 yaş grubunda saptandı, %62,7’si kadındı, SVT hastalarının hepsi 75 yaş altındaydı, %31,2’si kadındı. GİA/iskemik inme tanısı en sık 75-84 yaş grubundaydı, %54,4’ü erkekti. Akut iskemik inme tedavileri en çok 45 yaş altı inme grubuna (%31,2), en az 95 yaş üzerindeki gruba (%19,4) uygulanmıştı. Hastaların %67,4’ünde ön sistem tutulumu vardı. Ön ve arka sistem birlikte tutulumu (%5,5) en çok 95 yaş üzerinde görüldü. Etiyolojik araştırmalara rağmen 1385 (%41,9) hastada inme nedeni belirlenemedi. Kardiyoembolik inmeler yaş ile birlikte lineer olarak artış gösterdi. SONUÇ: Bu çalışma; inme merkezi hastalarının yaş gruplarına göre dağılımını göstermektedir. Kadınlarda yaş ile inme riskinin artması ve ileri etiyolojik araştırmalara rağmen nedeni belirlenemeyen iskemik inme oranı yüksekliği dikkat çekmektedir.
- 29 April 2024
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 25 (2) , 135-142
Open AccessİNMENİN YAŞ GRUPLARINA GÖRE DAĞILIMI - İSTANBUL'DA BİR İNME MERKEZİNİN DENEYİMLERİ
AMAÇ: İnme her yaşta görülebilen bir hastalıktır. İleri yaş hem hemorajik inme hem de iskemik inme için değiştirilemez risk faktörüdür ve ilerleyen on yıllarla birlikte risk artışı belirginleşir. Bu çalışmada akut inme hastalarının yaş gruplarına göre cinsiyet, inme etiyolojisi, uygulanan akut iskemi tedavileri, iskemi lokalizasyonu ve nedenleri arasındaki farklılıkların ortaya konulması amaçlandı. GEREÇ VE YÖNTEM: Eylül 2017 - Eylül 2020 arasında serebrovasküler olay tanısı ile yatarak tedavi gören ardışık 3665 hastanın yaş, cinsiyet, inme tipi, akut iskemik inme tedavisi ve etiyolojik sınıflamasına ait bilgileri retrospektif olarak değerlendirildi. BULGULAR: Hastaların 302’si hematom (%8,24), 51’i (%1,39) subaraknoid kanama (SAK), 13’ü (%0,35) serebral venöz tromboz (SVT), 3299’u (%90) geçici iskemik atak (GİA)/iskemik inme tanısı aldı. Kadınlarda inme sıklığı 65 yaş üzerinde artmaktaydı. İntraserebral hematom en sık 65-84 yaş aralığındaydı, %55,3’ü erkekti. SAK en sık 45-54 yaş grubunda saptandı, %62,7’si kadındı, SVT hastalarının hepsi 75 yaş altındaydı, %31,2’si kadındı. GİA/iskemik inme tanısı en sık 75-84 yaş grubundaydı, %54,4’ü erkekti. Akut iskemik inme tedavileri en çok 45 yaş altı inme grubuna (%31,2), en az 95 yaş üzerindeki gruba (%19,4) uygulanmıştı. Hastaların %67,4’ünde ön sistem tutulumu vardı. Ön ve arka sistem birlikte tutulumu (%5,5) en çok 95 yaş üzerinde görüldü. Etiyolojik araştırmalara rağmen 1385 (%41,9) hastada inme nedeni belirlenemedi. Kardiyoembolik inmeler yaş ile birlikte lineer olarak artış gösterdi. SONUÇ: Bu çalışma; inme merkezi hastalarının yaş gruplarına göre dağılımını göstermektedir. Kadınlarda yaş ile inme riskinin artması ve ileri etiyolojik araştırmalara rağmen nedeni belirlenemeyen iskemik inme oranı yüksekliği dikkat çekmektedir.
- 22 April 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (6) , 663-669
Mechanical thrombectomy for middle cerebral artery M2 occlusions
Background: The safety and efficacy of mechanical thrombectomy (MT) for proximal large vessel occlusion after acute ischemic stroke (AIS) have been demonstrated. Clinical investigations of endovascular approaches for treating AIS due to M2 occlusions have been ongoing. Purpose: To assess the outcomes of M2 occlusions according to treatment modality and anatomical division. Methods: A total of 113 consecutive M2 occlusions treated with endovascular treatment (EVT) at our tertiary stroke center between January 2019 and December 2022 were retrospectively analyzed. Patients were divided into three groups: mechanical thrombectomy (MT); intravenous thrombolysis plus MT (IVT + MT); and IVT alone. The primary outcomes were good prognosis (mRS = 0–2) and mortality (mRS = 6) on day 90. The secondary outcome was to determine the differences in outcomes between lesions in the superior and inferior branches of M2. Results: In total, 55 (48.7%) patients underwent MT. In 42 (37.2%) patients, bridging IVT was performed with MT, and IVT alone was applied in 16 (14.2%) patients. Neither the prognosis at 90 days nor the mortality rate significantly differed among the groups. The outcomes did not significantly differ between occlusions in the superior and inferior branches of M2. Conclusion: MT was found to be safe and effective for treating M2 occlusions in this series.
- 22 April 2024
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (6) , 663-669
Mechanical thrombectomy for middle cerebral artery M2 occlusions
Background: The safety and efficacy of mechanical thrombectomy (MT) for proximal large vessel occlusion after acute ischemic stroke (AIS) have been demonstrated. Clinical investigations of endovascular approaches for treating AIS due to M2 occlusions have been ongoing. Purpose: To assess the outcomes of M2 occlusions according to treatment modality and anatomical division. Methods: A total of 113 consecutive M2 occlusions treated with endovascular treatment (EVT) at our tertiary stroke center between January 2019 and December 2022 were retrospectively analyzed. Patients were divided into three groups: mechanical thrombectomy (MT); intravenous thrombolysis plus MT (IVT + MT); and IVT alone. The primary outcomes were good prognosis (mRS = 0–2) and mortality (mRS = 6) on day 90. The secondary outcome was to determine the differences in outcomes between lesions in the superior and inferior branches of M2. Results: In total, 55 (48.7%) patients underwent MT. In 42 (37.2%) patients, bridging IVT was performed with MT, and IVT alone was applied in 16 (14.2%) patients. Neither the prognosis at 90 days nor the mortality rate significantly differed among the groups. The outcomes did not significantly differ between occlusions in the superior and inferior branches of M2. Conclusion: MT was found to be safe and effective for treating M2 occlusions in this series.
- 13 October 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 193 (2) , 993-997
Symptomatic and asymptomatic pontine hyperintensities: are they central pontine myelinolysis? Case series
The diagnosis of central pontine hyperintensities on cranial magnetic resonance imaging has wide-spectrum clinical entities, and the pro-type diagnosis of these is central pontine myelinolysis. The rapid changes in extracellular environment due to an imbalance of electrolytes or metabolic or toxic stress to the myelin sheath can cause demyelination of white matter tracts in pons, which is why this situation could have different etiologies than just rapid sodium changes. Central pontine myelinolysis can be presented with different clinical scenarios from asymptomatic to death. Here, we present eight patients who had central pontine hyperintensities on radiological imaging but showed various clinical symptoms and different etiologies. The etiologies of these cases are hypertriglyceridemia, alcohol consumption, antidepressant usage, immunocompromised situations, uncontrolled diabetes mellitus, liver and kidney failure, electrolyte changes, and adrenal insufficiency. We aimed to take attention with this case series to the fact that not only fast correction of hyponatremia is the cause of central pontine myelinolysis, but also different etiologies could play a role in this situation, and making the central pontine myelinolysis diagnosis considering different diagnosis is very important.
- 13 October 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 193 (2) , 993-997
Symptomatic and asymptomatic pontine hyperintensities: are they central pontine myelinolysis? Case series
The diagnosis of central pontine hyperintensities on cranial magnetic resonance imaging has wide-spectrum clinical entities, and the pro-type diagnosis of these is central pontine myelinolysis. The rapid changes in extracellular environment due to an imbalance of electrolytes or metabolic or toxic stress to the myelin sheath can cause demyelination of white matter tracts in pons, which is why this situation could have different etiologies than just rapid sodium changes. Central pontine myelinolysis can be presented with different clinical scenarios from asymptomatic to death. Here, we present eight patients who had central pontine hyperintensities on radiological imaging but showed various clinical symptoms and different etiologies. The etiologies of these cases are hypertriglyceridemia, alcohol consumption, antidepressant usage, immunocompromised situations, uncontrolled diabetes mellitus, liver and kidney failure, electrolyte changes, and adrenal insufficiency. We aimed to take attention with this case series to the fact that not only fast correction of hyponatremia is the cause of central pontine myelinolysis, but also different etiologies could play a role in this situation, and making the central pontine myelinolysis diagnosis considering different diagnosis is very important.
- 26 June 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107862
Warfarin vs doac: Comparative outcomes of mechanical thrombectomy for acute ischemic stroke in atrial fibrillation patients
- 26 June 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 231, 107862
Warfarin vs doac: Comparative outcomes of mechanical thrombectomy for acute ischemic stroke in atrial fibrillation patients
- 3 April 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (5) , 574-578
Prediction of Bleeding by the PRECISE-DAPT Score in Patients with Carotid Artery Stenting
Purpose The predicting bleeding complications in patients undergoing stent implantation and the subsequent dual antiplatelet therapy (PRECISE-DAPT) score predicts the risk of bleeding in patients with dual antiplatelet therapy (DAPT) after percutaneous coronary interventions (PCIs). Patients with carotid artery stenting (CAS) are also treated with DAPT. In this study, we aimed to investigate the performance of the PRECISE-DAPT score in predicting bleeding in patients with CAS. Methods Patients who had CAS between January 2018 and December 2020 were retrospectively enrolled. The PRECISE-DAPT score was calculated for each patient. The patients were divided into two groups based on their PRECISE-DAPT score: low < 25 and high ≥ 25. Bleeding and ischemia complications and laboratory data among the two groups were compared. Results A total of 120 patients with a mean age of 67.3 ± 9.7 years were included. Forty-three patients had high PRECISE-DAPT scores, and 77 patients had low PRECISE-DAPT scores. Six patients developed bleeding events during the six-month follow-up, and five of them were in the PRECISE DAPT score ≥ 25 group. The difference between the two groups regarding bleeding events at six months was significant (P = 0.022). Conclusion The PRECISE-DAPT score might be used for predicting the bleeding risk in patients with CAS, and the bleeding rate was significantly higher in patients with a PRECISE-DAPT score ≥ 25.
- 3 April 2023
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 46 (5) , 574-578
Prediction of Bleeding by the PRECISE-DAPT Score in Patients with Carotid Artery Stenting
Purpose The predicting bleeding complications in patients undergoing stent implantation and the subsequent dual antiplatelet therapy (PRECISE-DAPT) score predicts the risk of bleeding in patients with dual antiplatelet therapy (DAPT) after percutaneous coronary interventions (PCIs). Patients with carotid artery stenting (CAS) are also treated with DAPT. In this study, we aimed to investigate the performance of the PRECISE-DAPT score in predicting bleeding in patients with CAS. Methods Patients who had CAS between January 2018 and December 2020 were retrospectively enrolled. The PRECISE-DAPT score was calculated for each patient. The patients were divided into two groups based on their PRECISE-DAPT score: low < 25 and high ≥ 25. Bleeding and ischemia complications and laboratory data among the two groups were compared. Results A total of 120 patients with a mean age of 67.3 ± 9.7 years were included. Forty-three patients had high PRECISE-DAPT scores, and 77 patients had low PRECISE-DAPT scores. Six patients developed bleeding events during the six-month follow-up, and five of them were in the PRECISE DAPT score ≥ 25 group. The difference between the two groups regarding bleeding events at six months was significant (P = 0.022). Conclusion The PRECISE-DAPT score might be used for predicting the bleeding risk in patients with CAS, and the bleeding rate was significantly higher in patients with a PRECISE-DAPT score ≥ 25.